Fortitude Family Office’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.89K | Buy |
+15
| New | +$1.89K | ﹤0.01% | 1226 |
|
|
2025
Q1 | – | Sell |
-6
| Closed | -$819 | – | 1244 |
|
|
2024
Q4 | $819 | Sell |
6
-11
| -65% | -$1.5K | ﹤0.01% | 1160 |
|
|
2024
Q3 | $1.96K | Buy |
17
+8
| +89% | +$922 | ﹤0.01% | 1007 |
|
|
2024
Q2 | $1.24K | Hold |
9
| – | – | ﹤0.01% | 861 |
|
|
2024
Q1 | $1.24K | Hold |
9
| – | – | ﹤0.01% | 891 |
|
|
2023
Q4 | $1.19K | Buy |
+9
| New | +$1.19K | ﹤0.01% | 930 |
|